2 Stories

FDA Approves Vaccine for Prostate Cancer

Provenge is first immunotherapy to gain approval

(Newser) - A first-of-a-kind prostate cancer treatment that uses the body's immune system to fight the disease received federal approval today, offering an important alternative to more taxing treatments like chemotherapy. Dendreon Corp.'s Provenge vaccine trains the immune system to fight tumors. It's called a "vaccine" even though it treats... More »

FDA Panel Passes First Cancer Vaccine

Prostate treatment recruits immune system to fight tumors

(Newser) - A cancer drug that's the first to harness the body's immune system to destroy tumors got a thumbs-up from  the FDA's advisory panel, the New York Times reports. If approved, Provenge, a prostate cancer treatment, would be the first of the "cancer vaccines"—experimental therapies that commandeer a... More »

2 Stories